migraine

News

Teva's migraine drug Ajovy looks set for EU approval

Teva’s migraine drug Ajovy (fremanezumab) has moved closer to the EU market after the influential CHMP regulatory committee gave it the green light.

News

A sad young woman is sitting in her kitchen with a headache

CVS covers migraine drugs from Teva and Lilly, excludes Amge...

US pharmacy benefits manager CVS Health Corp has added new migraine drugs from Teva and Eli Lilly to its list of covered drugs but excluded a rival from Amgen, according to a press report.<

News

NICE rejects Novartis’ migraine prevention drug Aimovig

Some migraine sufferers in the UK hoping to get access to Novartis’ new migraine prevention drug Aimovig are facing disappointment after NICE rejected it in draft guidance.

News

Lilly files new class migraine drug with FDA

Eli Lilly has filed a new migraine drug, lasmiditan, with the US regulator, the first drug in its class to be reviewed as a treatment for the condition.

News

Teva slumps after Express Scripts funds migraine rivals in U...

A major prescription benefit manager in the US will not reimburse Teva’s preventative migraine drug Ajovy (fremanezumab), in an effort to cut costs.

News

Lilly pushes into migraine market as Emgality approved in US

The FDA has approved Eli Lilly’s Emgality (galcanezumab) for migraine prevention in adults, the third in a group of new class of drugs for the condition.

Teva's migraine drug Ajovy looks set for EU approval

CVS covers migraine drugs from Teva and Lilly, excludes Amge...

NICE rejects Novartis’ migraine prevention drug Aimovig

Lilly files new class migraine drug with FDA

Teva slumps after Express Scripts funds migraine rivals in U...

Lilly pushes into migraine market as Emgality approved in US

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

migraine

Editor's Picks